That means Vioxx results cannot automatically be extended to Celebrex and Bextra which are in the Cox-2 classification with Vioxx but are not identical to it
The announcement comes just two weeks after Merck pulled its painkiller Vioxx which is in the same class of drugs as Bextra from the market because a study showed that the risk of heart attacks doubled for patients who had taken Vioxx for 18 months or longer
Vioxx and other Cox-2 inhibitors like Celebrex had been promoted as wonder drugs since they provided pain relief to arthritis sufferers without causing stomach problems but now Vioxx is off the market and the others are under a cloud
